Search - tctmd.com

Displaying 61 - 80 of 87

Sort: Relevancy | Date

News Conference News EAS 2019

Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients

Michael O'Riordan

May 30, 2019

News Conference News EAS 2019

CHD Mortality Significantly Elevated in Patients With Severe FH

Michael O'Riordan

May 29, 2019

News Conference News EuroPCR 2019

New Clarity on Patients at High Risk for Bleeding After PCI

Michael O'Riordan

May 28, 2019

News Conference News ESC Heart Failure 2019

Device-Based Therapy Offers REPRIEVE From Decongestion in Acute HF: TARGET 1 and 2

Shelley Wood

May 25, 2019

News Industry News

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

May 13, 2019

News Industry News

FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis

May 06, 2019

News Daily News

Digging In: Adherence to Plant-Based Diets Linked to Fewer HF Hospitalizations

L.A. McKeown

April 23, 2019

News Daily News

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

Michael O'Riordan

April 02, 2019

Presentation SIF 2019

Performing Zero (Or Low Volume) Contrast PCI in Patients with Advanced Chronic Kidney Disease

Presenter: Sripal Bangalore

March 28, 2019

News Daily News

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

News Conference News ACC 2019

Amlodipine the Key Component in Dual BP Therapy in Sub-Saharan Africa: CREOLE

Caitlin E. Cox

March 25, 2019

News Conference News ACC 2019

New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead

Michael O'Riordan

March 17, 2019

News Daily News

Bempedoic Acid Boosts LDL Cholesterol-Lowering in Statin-Treated CVD Patients: CLEAR Harmony

Michael O'Riordan

March 15, 2019

News Daily News

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

L.A. McKeown

March 13, 2019

News Daily News

DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit

Todd Neale

March 12, 2019

News Daily News

Updated AHA Scientific Statement Addresses CV Risk Reduction in High-Risk Youth

Todd Neale

March 05, 2019

News Daily News

ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD

Michael O'Riordan

March 01, 2019

News Daily News

Breast Calcifications May Hold Important Clues for CV Risk Stratification

L.A. McKeown

February 22, 2019

News Daily News

Quality of CAD Care Varies by Type of Medicare Coverage

Todd Neale

February 20, 2019

News Daily News

Similar MACCE in Coronary Patients With Diabetes and CKD Treated With CABG or PCI

L.A. McKeown

January 31, 2019

Advertisement

Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients

CHD Mortality Significantly Elevated in Patients With Severe FH

New Clarity on Patients at High Risk for Bleeding After PCI

Device-Based Therapy Offers REPRIEVE From Decongestion in Acute HF: TARGET 1 and 2

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis

Digging In: Adherence to Plant-Based Diets Linked to Fewer HF Hospitalizations

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

Performing Zero (Or Low Volume) Contrast PCI in Patients with Advanced Chronic Kidney Disease

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Amlodipine the Key Component in Dual BP Therapy in Sub-Saharan Africa: CREOLE

New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead

Bempedoic Acid Boosts LDL Cholesterol-Lowering in Statin-Treated CVD Patients: CLEAR Harmony

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit

Updated AHA Scientific Statement Addresses CV Risk Reduction in High-Risk Youth

ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD

Breast Calcifications May Hold Important Clues for CV Risk Stratification

Quality of CAD Care Varies by Type of Medicare Coverage

Similar MACCE in Coronary Patients With Diabetes and CKD Treated With CABG or PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content